Radiation Oncology

NCI-CCC Lymphoma Tumor Board Question

Questions discussed in this category

What is your approach to managing follicular lymphoma with central nervous system involvement?

Have you treated such cases with systemic therapies? If so, which ones (e.g., cytotoxic chemotherapy, anti-CD20 monoclonal antibodies, or targeted age...

1 Answer available

For a patient with ENKTL nasal type (nose/sinus involvement) who has hepatic toxicity with pegasparaginase but a CR after 2 cycles of chemotherapy with a plan for "sandwich" radiotherapy - what, if any, chemotherapy would you resume after completion of radiation?

I am not sure there is much efficacy for a regimen that does not include asparaginase. The patient received 2 cycles of P-GemOx, then was admitted for...

2 Answers available

Papers discussed in this category

Scientific reports, 2022 Nov 29

High-dose extended-field radiotherapy plus chemotherapy improved survival in extranodal NK/T-cell lymphoma in a real-life setting: results from the multicenter T-Cell Brazil Project.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-12-10

Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.

Blood, 2015 Jun 24

Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009 Oct 05

Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.

Radiation Oncology

NCI-CCC Lymphoma Tumor Board Question

Questions discussed in this category

Papers discussed in this category

Related Topics in Radiation Oncology